Changes in use of low-value services during the COVID-19 pandemic von Shahzad, Mahnum, Song, Zirui, Chernew, Michael E, Fendrick, A Mark

Volltext

Biosimilar competition: Early learning von Frank, Richard G., Shahzad, Mahnum, Kesselheim, Aaron S., Feldman, William

Volltext

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway von Shahzad, Mahnum, Naci, Huseyin, Esselen, Katharine M, Dottino, Joseph A, Wagner, Anita K

Volltext

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway von Shahzad, Mahnum, Naci, Huseyin, Wagner, Anita K

Volltext

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval von Shahzad, Mahnum, Naci, Huseyin, Wagner, Anita K

Volltext

Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer von Dottino, Joseph A., Esselen, Katharine M., Costa, Rebecca, Argetsinger, Stephanie, Shahzad, Mahnum, Ross-Degnan, Dennis, Wagner, Anita K.

Volltext

Biosimilar Competition: Early Learning von Frank, Richard G, Mahnum Shahzad, Feldman, William B, Kesselheim, Aaron S

Volltext